A new development combines CRISPR and GPT for automated gene-editing experiments. This technology, potentially created at Stanford, may enable faster gene therapies and could simplify the gene-editing process, possibly allowing those without extensive experience to achieve expert-level results. The implications of this development are being explored, with some considering its potential to accelerate scientific discovery.